1. Cbl-b silenced human NK cells respond stronger to cytokine stimulation. (4th November 2015) Authors: Lametschwandtner, Guenther; Sachet, Monika; Haslinger, Isabella; Mühleisen, Hannes; Loibner, Hans Journal: Journal for immunotherapy of cancer Issue: Volume 3(2015)Supplement 2 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Cbl-b silenced human NK cells respond stronger to cytokine stimulation. Issue 2 (December 2015) Authors: Lametschwandtner, Guenther; Sachet, Monika; Haslinger, Isabella; Mühleisen, Hannes; Loibner, Hans Journal: Journal for immunotherapy of cancer Issue: Volume 3:Issue 2(2015) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Development of a personalized cellular ex-vivo cbl-b silencing cancer immunotherapy. (6th November 2014) Authors: Lametschwandtner, Guenther; Loibner, Hans; Sachet, Monika; Hayden, Hubert; Hassler, Michaela; Schuster, Manfred; Salzberg, Marc; Triozzi, Pierre; Friedl, Josef Journal: Journal for immunotherapy of cancer Issue: Volume 2(2014)Supplement 3 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Metastatic colorectal carcinoma-associated fibroblasts have immunosuppressive properties related to increased IGFBP2 expression. (1st August 2022) Authors: Walterskirchen, Natalie; Müller, Catharina; Ramos, Cristiano; Zeindl, Stephan; Stang, Simone; Herzog, Daniela; Sachet, Monika; Schimek, Vanessa; Unger, Lukas; Gerakopoulos, Vasileios; Hengstschläger, Markus; Bachleitner-Hofmann, Thomas; Bergmann, Michael; Dolznig, Helmut; Oehler, Rudolf Journal: Cancer letters Issue: Volume 540(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Prognostic value of HMGB1 in early breast cancer patients under neoadjuvant chemotherapy. (25th July 2016) Authors: Exner, Ruth; Sachet, Monika; Arnold, Tobias; Zinn‐Zinnenburg, Mercedes; Michlmayr, Anna; Dubsky, Peter; Bartsch, Rupert; Steger, Guenther; Gnant, Michael; Bergmann, Michael; Bachleitner‐Hofmann, Thomas; Oehler, Rudolf Journal: Cancer medicine Issue: Volume 5:Number 9(2016:Sep.) Page Start: 2350 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. The novel polyclonal Ab preparation trimodulin attenuates ex vivo endotoxin-induced immune reactions in early hyperinflammation. Issue 6 (August 2019) Authors: Duerr, Celia; Bacher, Annica; de Martin, Angelika; Sachet, Monika; Sadeghi, Kambis; Baumann, Suzann; Heinz, Corina; Spittler, Andreas Journal: Innate immunity Issue: Volume 25:Issue 6(2019:Aug.) Page Start: 374 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Treatment of a cancer patient by an adoptive cell therapy protocol combining DC vaccination with cbl-b ex vivo silencing. (4th November 2015) Authors: Sachet, Monika; Lametschwandtner, Guenther; Hayden, Hubert; Hassler, Michaela; Loibner, Hans; Triozzi, Pierre; Friedl, Josef Journal: Journal for immunotherapy of cancer Issue: Volume 3(2015)Supplement 2 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Treatment of a cancer patient by an adoptive cell therapy protocol combining DC vaccination with cbl-b ex vivo silencing. Issue 2 (December 2015) Authors: Sachet, Monika; Lametschwandtner, Guenther; Hayden, Hubert; Hassler, Michaela; Loibner, Hans; Triozzi, Pierre; Friedl, Josef Journal: Journal for immunotherapy of cancer Issue: Volume 3:Issue 2(2015) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗